During the past decade, Marunouchi Hospital conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 5 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 5 clinical trials were completed. i.e. 500% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Marunouchi Hospital" #1 collaborator was "Eli Lilly and Company" with 3 trials as a collaborator and "Bristol-Myers Squibb" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Marunouchi Hospital" are "Osteoarthritis, Hip" (2 trials), "Osteoarthritis, Knee" (2 trials), "Arthroplasty, Replacement, Knee" (1 trials), "Chronic Pain" (1 trials) and "Low Back Pain" (1 trials). Many other conditions were trialed in "Marunouchi Hospital" in a lesser frequency.

Most popular intervention types in "Marunouchi Hospital" are "Drug" (5 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Enoxaparin 40 mg" (1 trials), "Investigational Medical Product (IMP) administered in parent study" (1 trials), "JNJ-70033093 100 mg" (1 trials) and "JNJ-70033093 200 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Marunouchi Hospital" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Marunouchi Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Marunouchi Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Marunouchi Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".